Signal Transduct Target Ther May 2023 PMID 37208335

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.

Chen Xue, Qinfan Yao, Xinyu Gu, Qingmiao Shi, Xin Yuan, Qingfei Chu, Zhengyi Bao, Juan Lu, Lanjuan Li

Download social card

Mentions

7
Peak: 1 in Aug 2023
across 4 sources since Aug 2023

Extended reach

1,778
potential audience

Total likes

4

Video views

138

Mentions per month

Aug 2023 – Jul 2025

Where it's discussed

  • X / Twitter2 posts
  • News2 articles
  • Blogs2 articles
  • YouTube1 videos

AI synopsis

What people are saying

The discussions emphasize the significance of the JAK-STAT pathway in disease management, with remarks like 'transformative therapies' and questions about recent advancements, showing both interest and engagement. The use of positive language and technical references indicates recognition of the research's potential influence on medical approaches.

AgreementModerate agreement

Most discussions reflect a consensus that the article provides valuable insights into the JAK-STAT pathway's role in disease, with comments highlighting its importance in immune regulation and cancer.

InterestHigh interest

The discussions show high interest, as users express curiosity about the mechanisms and therapeutic developments, using words like 'fascinating' and 'crucial.'

EngagementModerate engagement

Comments often delve into specifics of the research, such as therapeutic strategies and pathway regulation, indicating active engagement.

ImpactModerate impact

Participants believe the research could influence future treatments and understanding of autoimmune diseases and cancers, suggesting moderate to high impact perceived.

Abstract in brief

  • The JAK-STAT pathway is a conserved cell communication mechanism activated by cytokines and growth factors, playing key roles in processes like immune response, inflammation, and cancer.
  • Dysregulation and genetic mutations in JAK-STAT signaling are closely linked to immune disorders and cancer progression, leading to the development of targeted therapies such as cytokine antibodies, JAK inhibitors, and STAT inhibitors.
  • Ongoing research continues to improve understanding of the pathway, develop novel drugs, and address challenges in treatment safety and efficacy for immune-related diseases and malignancies.

Top posts

Most liked on X and Bluesky
Abdul M. Ssekandi, MBChB, MSc., M.A.P.S
@JC_by_AMS · X

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer Chen Xue et al. https://t.co/rMSIMrwemb https://t.co/IMg3l2USc0

Jul 27, 2025 · 4 likes · 1,123 followers View post →
Dr Alison B
@AliBliPCdoc · X

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer | Signal Transduction and Targeted Therapy https://t.co/DPu5RJnDPU

Jul 14, 2024 · 517 followers View post →

All mentions

Abdul M. Ssekandi, MBChB, MSc., M.A.P.S
@JC_by_AMS · X

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer Chen Xue et al. https://t.co/rMSIMrwemb https://t.co/IMg3l2USc0

Jul 27, 2025 · 4 likes · 1,123 followers View post →
Dr Alison B
@AliBliPCdoc · X

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer | Signal Transduction and Targeted Therapy https://t.co/DPu5RJnDPU

Jul 14, 2024 · 517 followers View post →